Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease

Gut

Volumn 46, Issue 1, 2000, Pages 58-63

  Sutton, C L ^a   Yang, H ^b   Li, Z ^b   Rotter, J I ^b   Targan, S R ^b   Braun, J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Anti mannan antibodies; Crohn's disease; Inflammatory bowel disease; Intraclass correlation; Statistical genetics; Ulcerative colitis

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MANNAN;

ADULT; ANTIBODY DETECTION; ARTICLE; CELL WALL; CHILD; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL INCIDENCE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RELATIVE; SACCHAROMYCES CEREVISIAE; SIBLING; SPOUSE;

ADULT; ANTIBODIES, FUNGAL; CHILD; CROHN DISEASE; FAMILY HEALTH; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MANNANS; SACCHAROMYCES CEREVISIAE;

EID: 0034108625     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.1.58     Document Type: Article

References (51)

1. 1 D'Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998;114:262-7.
2. 2 Prantera C, Zannoni F, Scribano ML, et al. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 1996;91:328-32.
3. 3 Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995;108:1617-21.
4. 4 Janowitz HD, Croen EC, Sachar DB. The role of the fecal stream in Crohn's disease: an historical and analytic review. Inflammatory Bowel Disease 1998;4:29-39.
5. 5 Gui GPH, Thomas PRS, Tizard MLV, et al. Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. J Antimicrob Chemother 1997;39: 393-400.
6. 6 Wayne LG, Hollander D, Anderson B, et al. Immunoglobulin A (IgA) and IgG serum antibodies to mycobacterial antigens in patients with Crohn's disease and their relatives. J Clin Microbiol 1992;30:2013-18.
7. 7 Blaser MJ, Miller RA, Lacher J, et al. Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology 1984; 87:888-94.
8. 8 Vannuffel P, Dieterich C, Naerhuyzen B, et al. Occurrence, in Crohn's disease, of antibodies directed against a species-specific recombinant polypeptide of Mycobacterium paratuberculosis. Clin Diag Lab Immunol 1994;1:241-3.
9. 9 Liu Y, Van Kruiningen HJ, West AB, et al. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 1995;108:1396-404.
10. 10 Elsaghier A, Prantera C, Moreno C, et al. Antibodies to Mycobacterium paratuberculosis-specific protein antigens in Crohn's disease. Clin Exp Immunol 1992;90:503-8.
11. 11 Pirzer U, Schonhaar A, Fleischer B, et al. Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease. Lancet 1991;338:1238-9.
12. 12 Young CA, Sonnenberg A, Burns EA. Lymphocyte proliferation response to Baker's yeast in Crohn's disease. Digestion 1994;55:40-3.
13. 13 Brandwein SL, McCabe RP, Cong Y, et al. Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J Immunol 1997;159:44-52.
14. 14 Rath HC, Herfarth HH, Ikeda JS, et al. Normal luminal bacteria, especially bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest 1996;98:945-53.
15. 15 Herfarth HH, Mohanty SP, Rath HC, et al. Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers. Gut 1996; 39:836-45.
16. 16 Dianda L, Hanby AM, Wright NA, et al. T cell receptor-alpha,beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol 1997; 150:91-7.
17. 17 Davidson IW, Lloyd RS, Whorwell PJ, et al. Antibodies to maize in patients with Crohn's disease, ulcerative colitis, and coeliac disease. Clin Exp Immunol 1979;35:147-8.
18. 18 Knoflach P, Park BH, Cunningham R, et al. Serum antibodies to cow's milk proteins in ulcerative colitis and Crohn's disease. Gastroenterology 1987;92:479-85.
19. 19 Falchuk KR, Isselbacher KJ. Circulating antibodies to bovine serum albumin in ulcerative colitis and Crohn's disease. Gastroenterology 1976;70:5-8.
20. 20 Sonnenberg A. Occupational distribution of inflammatory bowel disease among German employees. Gut 1990;31: 1037-40.
21. 21 Van Kruiningen HJ, Colombel JF, Cartun RW, et al. An in-depth study of Crohn's disease in two French families. Gastroenterology 1993;104:351-60.
22. 22 Tysk C, Riedesel H, Lindgerg E, et al. Colonic glycoproteins in monozygotic twins with inflammatory bowel disease. Gastroenterology 1991;100:419-23.
23. 23 Roth M-P, Petersen GM, McElree C, et al. Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology 1989;97:900-4.
24. 24 Yang H-Y, McElree C, Shanahan F, et al. Familial empiric risks for inflammatory bowel disease. Differences between Jews and non-Jews. Gut 1993;34:517-22.
25. 25 Peeters M, Geypens B, Claus D, et al. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 1997;113:802-7.
26. 26 Akolkar PN, Gulwani-Akolkar B, Heresbach D, et al. Differences in risk of Crohn's disease in offspring of mothers and fathers with inflammatory bowel disease. Am J Gastroenterol 1997;92:2241-4.
27. 27 Toyoda H, Wang S-J, Yang H-Y, et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993;104:741-8.
28. 28 Yang H-Y, Vora KA, Targan SR, et al. Intercellular adhesion molecule 1 gene association with immunologic subsets of inflammatory bowel disease. Gastroenterology 1995;109; 440-6.
29. 29 Plevy SE, Targan SR, Yang H-Y, et al. Tumor necrosis factor microsatellite define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology 1996;110:1053-60.
30. 30 Bouma G, Poen AC, Garcia-Gonzalez MA, et al. HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease. Immunogenetics 1998;47:451-5.
31. 31 Cariappa A, Sands B, Forcione D, et al. Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease. Gut 1998;43:210-15.
32. 32 Roussomoustakaki M, Satsangi J, Welsh K, et al. Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 1997;112:1845-53.
33. 33 Hugot J-P, Laurent-Puig P, Gower-Rousseau C, Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996;379:821-3.
34. 34 Ohmen JD, Yang H-Y, Yamamoto KK, et al. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. Hum Mol Genet 1996;5:1679-83.
35. 35 Satsangi J, Parkes M, Louis E, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 1996;14:199-202.
36. 36 Duerr RH, Barmada MM, Zhang L, et al. Linkage and association between inflammatory bowel disease and a locus on chromosome 12. Am J Hum Genet 1998;63:95-100.
37. 37 Duerr RH, Targan SR, Landers CJ, et al. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 1991;100:1590-6.
38. 38 Yang H-Y, Rotter JI, Toyoda H, et al. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest 1993;92:1080-4.
39. 39 Shanahan F, Duerr RH, Rotter JI, et al. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992;103:456-61.
40. 40 Satsangi J, Landers CJ, Welsh KI, et al. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease. Inflammatory Bowel Disease 1998;4:18-26.
41. 41 Lindberg E, Magnusson KE, Tysk C, et al. Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin, and betalactoglobulin in monozygotic twins with inflammatory bowel disease. Gut 1992;33:909-13.
42. 42 Sendid B, Colombel JF, Jacquinot PM, et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diag Lab Immunol 1996;3:219-26.
43. 43 McKenzie H, Main J, Pennington CR, et al. Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. Gut 1990;31:536-8.
44. 44 Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998;42:788-91.
45. 45 Sendid B, Quinton JF, Charrier G, et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol 1998;93:1306-10.
46. 46 Falconer DS. Introduction to quantitative genetics. 3rd ed. Essex: Longman Scientific and Technical Company, 1981.
47. 47 Sokal RR, Rohlf FJ. Biometry: the principles and practice of statistics in biological research. 3rd ed. New York: WH Freeman and Company, 1995.
48. 48 Karlin S, Cameron EC, Williams PT. Sibling and parent-offspring correlation estimation with variable family size. Proc Natl Acad Sci USA 1981;78:2664-8.
49. 49 Lillioja S, Mott DM, Zawadzki JK, et al. In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 1987;36:1329-35.
50. 50 Hollander D, Vadheim CM, Brettholz E, et al. Increased intestinal permeability in Crohn's patients and their relatives: an etiologic factor? Ann Intern Med 1986;105: 883-5.
51. 51 Ruemmele FM, Targan SR, Levy G, et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998;115:822-9.